Article
Systemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy.
Expert opinion on pharmacotherapy - 1 Apr 2015
Collins Dearbhaile Catherine, Morris Patrick Glyn
Abstract excerpt
INTRODUCTION: Pancreatic cancer is an aggressive solid tumour associated with a high risk of local invasion and metastatic spread. In the absence of validated screening approaches, many patients present with advanced, incurable disease. Despite advances in treatment, the prognosis for patients with advanced pancreatic cancer remains poor. The benefits of surgical resection and radiation are unproven in this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
